Results 261 to 270 of about 276,079 (291)
Abstract Background Older adults with type 2 diabetes (T2DM) are less likely to receive sodium–glucose cotransporter‐2 (SGLT2) inhibitors, despite their proven cardio‐renal benefits and safety. Whether this age‐related gap is driven by frailty, sex, or other factors remains unclear.
Changyuan Yang +6 more
wiley +1 more source
Acute Coronary Syndrome With Giant Pancoronary and Ascending-Descending Aortic Aneurysms. [PDF]
Velasquez-Orozco GA +5 more
europepmc +1 more source
Association of Ticagrelor Metabolic SNPs With Adverse Drug Reactions in Patients With Acute Coronary Syndrome. [PDF]
Zhang Y +5 more
europepmc +1 more source
Differential Effects of Intravenous Versus Intracoronary Adenosine on Non-Culprit Lesion Assessment Following Acute Coronary Syndrome. [PDF]
Los J +12 more
europepmc +1 more source
Antithrombotic Therapy for Acute Coronary Syndrome. [PDF]
Toyota T +4 more
europepmc +1 more source
Treatment charges for acute coronary syndrome: A retrospective analysis. [PDF]
Frizzell L +8 more
europepmc +1 more source
Heated Tobacco Product Spread and Hospitalizations for Acute Coronary Syndrome in Japan.
Iwanaga Y +4 more
europepmc +1 more source
Bleeding Outcomes of Ticagrelor Versus Clopidogrel in Acute Coronary Syndrome Patients: A Multiethnic Database Study. [PDF]
Loh GL +8 more
europepmc +1 more source

